PARVB was hypomethylated in the livers of patients with advanced NAFLD, PNPLA3 was hypermethylated in these patients. The levels of SAMM50 mRNA did not differ between patients with mild or advanced NAFLD. This evidence concerns the gene SAMM50 and metabolic dysfunction-associated steatotic liver disease.